Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2014-08-06 Interim / Quarterly Rep…
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q2 2014
2014-08-06 English
PRIMARY DOCUMENT
Director's Dealing
2014-07-01 English
FORM 8-K
Capital/Financing Update Classification · 90% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifies that the filing includes a press release updating the company's substance abuse testing business and second quarter 2014 financial guidance. The document is relatively short (3267 characters) and primarily serves to announce and attach a press release rather than provide detailed financial statements or comprehensive analysis. It does not contain full financial results or detailed management discussion, but rather an update and guidance. This fits the profile of a Capital/Financing Update (CAP) as it relates to financial guidance updates and business updates. It is not an Earnings Release (ER) because it is not the initial announcement of quarterly results but an update on guidance. It is not a Regulatory Filing (RNS) fallback because the content is specific to financial guidance update. Therefore, the best classification is Capital/Financing Update (CAP).
2014-06-25 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement between OraSure Technologies and AbbVie, including details of the agreement and related payments. It also references a webcast conference call with prepared remarks attached as exhibits. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The primary focus is on the announcement of a significant agreement and related investor communication. This fits the category of Capital/Financing Update (CAP), as it involves a material definitive agreement related to co-promotion and exclusivity payments, which are financing-related activities. The document length is sufficient and contains substantive information about the agreement, not just a brief announcement or a certification. Therefore, the best classification is CAP with high confidence.
2014-06-11 English
FORM SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filing, which is a Specialized Disclosure Report related to conflict minerals under Rule 13p-1 of the Securities Exchange Act. It is not an annual report, quarterly report, or earnings release. The document contains a conflict minerals disclosure for the calendar year 2013, including supplier information and origin of minerals. The length is 3028 characters, which is relatively short and focused on a specific regulatory disclosure. Form SD filings are specialized disclosures and do not fit into categories like Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2014-05-28 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 22, 2014, by OraSure Technologies, Inc. The content focuses on the submission of matters to a vote of security holders at the Annual Meeting of Stockholders, including election of directors, ratification of auditors, advisory resolution on executive compensation, and approval of stock plan amendments. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings. The document length is 2964 characters, which is short but contains detailed voting results, not just an announcement of a report. Therefore, it is not a Report Publication Announcement or Regulatory Filing. The presence of voting results and shareholder meeting items confirms classification as DVA.
2014-05-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.